LB

Lakkanna Bharthi

Director Director DIN 09045412
DIN 09045412 First appointment Jan 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2021
Shareholding value Locked Premium profile

About Lakkanna Bharthi

Lakkanna Bharthi has 5 years in corporate governance. Formerly with 1 company, such as Tykes Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09045412
Primary Designation Director
First Appointment 28 Jan 2021
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Tykes Pharma Private Limited U24299KA2021PTC143591
Director 28 Jan 2021 2021 Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Tykes Pharma Private Limited
Premium access

Shareholding and investment profile for Lakkanna Bharthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lakkanna Bharthi

Lakkanna Bharthi has 5 years in corporate governance. Formerly with 1 company, such as Tykes Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Lakkanna Bharthi is associated with 0 companies as a director.

Lakkanna Bharthi has expertise in General Business.

Lakkanna Bharthi has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available